Brain Development Research Program
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of California, San Francisco
About this trial
Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of brain development that affect the corpus callosum, such as Aicardi syndrome, as well as two additional brain malformations, polymicrogyria and Dandy-Walker malformation. The goal of the investigators' research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients.
Eligibility criteria
Qualifiers
Clinical diagnosis of agenesis or dysgenesis of the corpus callosum, polymicrogyria, or Dandy-Walker malformation
Should be confirmed by an MRI (Magnetic Resonance Imaging) of the brain
Disqualifiers
Fully formed but hypoplastic corpus callosum
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
University of California, San Francisco
Lead sponsor
University of Washington
Collaborator
California Institute of Technology
Collaborator
Source ClinicalTrials.gov